Chikungunya — Vax-Before-Travel

Fact checked by Robert Carlson, MD

Jan 14

4 min read

Chikungunya Vaccine Candidate To Begin Testing in Europe

Emergent BioSolutions’ CHIKV-VLP vaccine is being developed for the prevention of disease caused by a chikungunya virus infection

antwerp belgium office building

Tropical Diseases

Fact checked by Robert Carlson, MD

Jan 7

4 min read

Chikungunya Vaccine Is On The FDA’s Fast-Track

Chikungunya vaccine VLA1553 is a monovalent single dose live attenuated vaccine candidate

fast motorcycle track

Fact checked by Robert Carlson, MD

Nov 22

4 min read

Chikungunya VLP Vaccine Candidate Reports Positive Dosing Results

Emergent BioSolutions CHIKV VLP vaccine candidate produced neutralizing antibody responses against the chikungunya virus in most patients within 7 days after vaccination

fireworks in sky

Tropical Diseases

Fact checked by Robert Carlson, MD

Nov 18

4 min read

Chikungunya Vaccine Candidate Delivered Excellent Study Results

Valneva chikungunya vaccine candidate VLA1553 was generally safe in all dose groups and the local tolerability profile was excellent

mountain hiker

Fact checked by Danielle Reiter, RN

Nov 14

7 min read

Sterilizing Mosquitoes To Kill Off Infectious Diseases

Sterilized male mosquitoes will mate with females in the wild to reduce future generations

south beach florida